Year-to-date money raised in public, private and other financings of biopharma companies.

Total raised in public, private and other financings of biopharma companies, comparing 2023 vs. 2022 vs. 2021 vs. 2020 vs. 2019.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Apex, Aquestive, Cantargia, Carsgen, DBV, Dermata, Genentech, Innocare, Regeneron, Sanofi, Sensei, Therapeutic Solutions, Tiziana.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Boehringer Ingelheim, Emergent, Genmab, GRI, Janssen, Retinai, Vallon, Ventus.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Achieve, Beigene, Bioinvent, Cantex, Dare, Maia, Promore, Sellas, Visus.

Biopharmas raising money in public or private financings, including: Cyclo, Pharmaessentia, Phio, Sirona.

New hires and promotions in the biopharma industry, including: Allogene, Immvira, Lianbio.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: GE Healthcare, Meridian Bioscience, Noctrix Health.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbott Laboratories, Cercare Medical, Concertai, Element Biosciences, Epic Sciences, Gemina, Grail, Illumina, Mdxhealth, Nvidia, Radimagenet, Readygo, Science 37, Segmed, Surmodics

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Bend Health, Grail, Icecure Medical, Vialase.